Skip to main content

Advertisement

SpringerLink
Log in

On combining antineoplastic drugs with tumor vaccines

  • Symposium in Writing
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Arinaga S, Akiyoshi T, Tsuji H (1986) Augmentation of the generation of cell-mediated cytotoxicity after a single does of adriamycin in cancer patients. Cancer Res 46:4213

    CAS  PubMed  Google Scholar 

  2. Asavaroengchai W, Kotera Y, Mulé JJ (2002) Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery. Proc Natl Acad Sci U S A 99:931

    Article  CAS  PubMed  Google Scholar 

  3. Awwad M, North RJ (1988) Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour: evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumor burden. Immunology 65:87

    CAS  PubMed  Google Scholar 

  4. Berd D, Maguire HCJ, Mastrangelo MJ (1986) Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. Cancer Res 46:2572

    CAS  PubMed  Google Scholar 

  5. Berd D, Sato T, Cohn H, Maguire HCJ, Mastrangelo MJ (2001) Treatment of metastatic melanoma with autologous hapten-modified melanoma vaccine: regression of pulmonary metastates. Int J Cancer 94:531

    CAS  PubMed  Google Scholar 

  6. Chan OTM, Yang L-X (2000) The immunological effects of taxanes. Cancer Immunol Immunother 49:181

    Article  CAS  PubMed  Google Scholar 

  7. Chuang LT, Lotzová E, Heath J, Cook KR, Heath J, Cook KR, Munkarah A, Morris M, Wharton JT (1994) Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol. Cancer Res 54:1286

    CAS  PubMed  Google Scholar 

  8. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298:850

    Google Scholar 

  9. Dummer W, Niethammer AG, Baccala R, Lawson BR, Wagner N, Reisfeld RA, Theofilopoulos AN (2002) T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest 110:185

    Article  CAS  PubMed  Google Scholar 

  10. Ehrke MJ, Maccubbin D, Ryoyama K, Cohen SA, Mihich E (1986) Correlation between adriamycin-induced augmentation of interleukin-2 production and of cell-mediated cytotoxicity in mice. Cancer Res 46:54

    CAS  PubMed  Google Scholar 

  11. Ehrke MJ, Mihich E, Berd D, Mastrangelo MJ (1989) Effects of anticancer drugs on the immune system in humans. Semin Oncol 16:230

    Google Scholar 

  12. Emens LA, Machiels J-P, Reilly RT, Jaffee EM (2001) Chemotherapy: Friend or foe to cancer vaccines? Curr Opin Mol Ther 3:77

    CAS  PubMed  Google Scholar 

  13. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A 89:10578

    CAS  PubMed  Google Scholar 

  14. Hoover SK, Barrett SK, Turk TMT, Lee T-C, Bear HD (1990) Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity. Cancer Immunol Immunother 31:121

    CAS  PubMed  Google Scholar 

  15. Hu H-M, Poehlein CH, Urba WJ, Fox BA (2002) Development of antitumor immune responses in reconstituted lymphopenic hosts. Cancer Res 62:3914

    CAS  PubMed  Google Scholar 

  16. Kerckhaert JA, Hofhuis FM, Willers JM (1977) Effects of variation in time and dose of cyclophosphamide injection on delayed-type hypersensitivity and antibody formation. Cell Immunol 29:232

    CAS  PubMed  Google Scholar 

  17. Maccubbin DL, Wing KR, Mace KF, Ho RLX, Ehrke J, Mihich E (1992) Adriamycin-induced modulation of host defenses in tumor-bearing mice. Cancer Res 52:3572

    CAS  PubMed  Google Scholar 

  18. Mace K, Mayhew E, Mihich E, Ehrke MJ (1988) Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin. Cancer Res 48:130

    CAS  PubMed  Google Scholar 

  19. Machiels J-PH, Reilly RT, Emens LA, Ercolini AM, Lei RY, Weintraub D, Okoye FI, Jaffee EM (2001) Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res 61:3689

    CAS  PubMed  Google Scholar 

  20. Maguire HC Jr, Maibach HI (1961) Effect of cyclophosphamide, 6-mercaptopurine, actinomycin D, and vincaleukoblastine on the acquisition of delayed hypersensitivity (DNCB contact dermatitis) in the guinea-pig. J Invest Derm 37:427

    CAS  Google Scholar 

  21. Maguire HCJ, Maibach HI (1961) Specific immune tolerance to anaphylactic sensitization (egg albumin) induced in the guinea pig by cyclophosphoramide (cytoxan). J Allergy 32:406

    Google Scholar 

  22. Maguire HCJ, Maibach HI, Minisce LWJ (1961) Inhibition of guinea pig anaphylactic sensitization with cyclophosphoramide. J Invest Derm 36:256

    Google Scholar 

  23. Manthey CL, Perera P-Y, Salkowski CA, Vogel SN (1994) Taxol provides a second signal for murine macrophage tumoricidal activity. J Immunol 152:825

    CAS  PubMed  Google Scholar 

  24. Mullins DW, Burger CJ, Elgert KD (1999) Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. J Immunol 162:6811

    CAS  PubMed  Google Scholar 

  25. Nigam A, Yacavone RF, Zahurak ML, Johns CMS, Pardoll DM, Piantadosi S, Levitsky HI, Nelson WG (1998) Immunomodulatory properties of antineoplastic drugs administered in conjunction with GM-CSF-secreting cancer cell vaccines. Int J Oncol 12:161

    CAS  PubMed  Google Scholar 

  26. Orsini F, Pavelic Z, Mihich E (1977) Increased primary cell-mediated immunity in culture subsequent to adriamycin or danorubicin treatment of spleen donor mice. Cancer Res 37:1719

    CAS  PubMed  Google Scholar 

  27. Polak L, Geleick H, Turk JL (1975) Reversal by cyclophosphamide of tolerance in contact sensitization. Tolerance induced by prior feeding with DNCB. Immunology 28:939

    CAS  PubMed  Google Scholar 

  28. Porgador A, Snyder D, Gilboa E (1996) Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 156:2918

    CAS  PubMed  Google Scholar 

  29. Proietti E, Greco G, Garrone B, Baccarini S, Mauri C, Venditti M, Carlie D, Belardelli F (1998) Importance of cyclophosphamide-induced bystander effect on T Cells for a successful tumor eradication in response to adoptive immunotherapy in mice. J Clin Invest 101:429

    CAS  PubMed  Google Scholar 

  30. Reilly RT, Gottlieb MBC, Ercolini AM, Machiels J-PH, Kane CE, Okoye FI, Muller WJ, Dixon KH, Jaffee EM (2000) HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice. Cancer Res 60:3569

    CAS  PubMed  Google Scholar 

  31. Schiavoni G, Mattei F, Pucchio TD, Santini SM, Bracci L, Belardelli F, Proietti E (2000) Cyclophosphamide induces type I interferon and augments the number of CD44hi T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer. Blood 95:2024

    CAS  PubMed  Google Scholar 

  32. Shimizu K, Fields RC, Giedlin M, Mulé JJ (1999) Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. Proc Natl Acad Sci U S A 96:2268

    Article  CAS  PubMed  Google Scholar 

  33. Taniguchi M, Tada T (1971) Regulation of homocytotropic antibody formation in the rat. IV. Effects of various immunosuppressive drugs. J Immunol 107:579

    CAS  PubMed  Google Scholar 

  34. Yoshida S, Nomoto K, Himeno K, Takeya K (1979) Immune response to syngeneic or autologous testicular cells in mice. I. Augmented delayed footpad reaction in cyclophosphamide-treated mice. Clin Exp Immunol 38:211

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Center for Immunology and Immunotherapy, University of Michigan Medical Center, 1150 West Medical Center Drive, 1520 MSRB 1, Ann Arbor, MI 48109, USA

    Alicia Terando & James J. Mulé

Authors
  1. Alicia Terando
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James J. Mulé
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James J. Mulé.

Additional information

This article forms part of the Symposium in Writing on "Cellular immunity for cancer chemoimmunotherapy" in Volume 52 (2003)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terando, A., Mulé, J.J. On combining antineoplastic drugs with tumor vaccines. Cancer Immunol Immunother 52, 680–685 (2003). https://doi.org/10.1007/s00262-003-0426-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-003-0426-3

Keywords

Search

Navigation